GlassScriptPhysician profile
Philip S Carson
NPI 1952665887
$11,989.00
in general payments reported to CMS, 2019-2025
33 companies · $1,629 in 2025
The $1,629 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,857 · 2020: $455 · 2021: $1,642 · 2022: $1,519 · 2023: $1,085 · 2024: $802 · 2025: $1,629.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,499 · Education: $17.26.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,498.80 |
| Education | $17.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $1,680.21 | 2019-2025 | Impella |
| Abbott Laboratories | $1,415.94 | 2019-2023 | Coroflow |
| Cardiovascular Systems INC. | $1,394.25 | 2019-2020 | |
| Imperative Care, INC | $1,295.24 | 2024-2025 | Symphony Catheter, Prodigy Catheter, Hotshot Controller |
| Philips North America LLC | $1,074.06 | 2019-2023 | |
| Boston Scientific Corporation | $873.11 | 2019-2024 | Wolverine Coronary Cutting Balloon, Watchman Access System, Rotapro |
| Novartis Pharmaceuticals Corporation | $460.25 | 2019-2025 | |
| Amgen INC. | $450.02 | 2019-2025 | Repatha, Repatha |
| Medtronic, INC. | $448.08 | 2021-2022 | |
| Edwards Lifesciences Corporation | $439.77 | 2019-2025 | Sapien 3 Ultra Resilia |
| Inari Medical, INC. | $307.53 | 2023-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Janssen Pharmaceuticals, INC | $259.41 | 2020-2022 | |
| Shockwave Medical, INC | $232.36 | 2021 | |
| Medtronic Vascular, INC. | $206.26 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $188.73 | 2019-2023 | Jardiance |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $179.64 | 2019-2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $148.32 | 2019-2023 | Lifevest |
| Actelion Pharmaceuticals US, INC. | $148.03 | 2020-2023 | Uptravi, Opsumit |
| Penumbra, INC. | $132.64 | 2023 | Indigo System |
| Pfizer INC. | $114.93 | 2022-2023 | |
| Merck Sharp & Dohme LLC | $92.35 | 2022-2023 | Verquvo |
| Bayer Healthcare Pharmaceuticals INC. | $90.25 | 2022-2023 | |
| Amarin Pharma, INC. | $55.43 | 2020-2022 | |
| Biotronik INC. | $48.99 | 2019 | |
| Chiesi USA, INC. | $34.97 | 2019-2022 | |
| Livanova USA, INC. | $34.51 | 2020 | |
| Stryker Corporation | $34.07 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Avinger INC. | $33.36 | 2021 | |
| Cvrx, INC. | $31.16 | 2022-2023 | Barostim Neo System |
| Atricure, INC. | $28.61 | 2025 | Epi-Sense Guided Coagulation System With Visitrax |
| Daiichi Sankyo INC. | $26.97 | 2022-2023 | Injectafer |
| Kiniksa Pharmaceuticals, LTD. | $16.82 | 2021 | |
| Esperion Therapeutics, INC. | $12.73 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Philip Carson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.